John Baldoni - 09 Mar 2022 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
/s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol
INKT
Transactions as of
09 Mar 2022
Transactions value $
$0
Form type
4
Date filed
11 Mar 2022, 15:12
Previous filing
20 Oct 2021
Next filing
19 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INKT Stock Option (Right to Buy) Award $0 +15K $0.00 15K 09 Mar 2022 Common Stock 15K $2.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.